2-(3-methoxyphenyl)-5-nitropyridine | 951024-89-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(3-methoxyphenyl)-5-nitropyridine
• CAS: 951024-89-8
• 化学式: C₁₂H₁₀N₂O₃
• 分子量: 230.223
• InChiKey: YDVFLUNAJDOLJF-UHFFFAOYSA-N

物化性质

• 熔点：
  105-106 °C(Solvent: Ethanol)
• 沸点：
  372.6±27.0 °C(Predicted)
• 密度：
  1.252±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  67.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(3-methoxyphenyl)-5-nitropyridine 在 水 、 铁粉 、 氯化铵 作用下， 以 乙醇 为溶剂， 反应 1.0h， 生成 6-(3-methoxyphenyl)pyridin-3-amine
  参考文献：
  名称：

  [EN] NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS
  [FR] NOUVEAUX COMPOSÉS IMMUNOMODULATEURS ET ANTI-INFLAMMATOIRES

  摘要：

  本发明提供了式(I)的脱氢二氢乳酸脱氢酶抑制剂，其制备方法，含有它们的药物组合物以及治疗、预防和/或改善已知抑制二氢乳酸脱氢酶显示有益效果的疾病或疾病的方法。

  公开号：

  WO2011138665A1
• 作为产物：
  描述：

  1-甲基-3,5-二硝基-2-吡啶酮 、 3-甲氧基苯乙酮 在 氨 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以93%的产率得到2-(3-methoxyphenyl)-5-nitropyridine
  参考文献：
  名称：

  Nitropyridines: VI. Synthesis of 2-aryl(hetaryl)- and 2,3-polymethylene-5-nitropyridines

  摘要：

  Previously unknown 2-aryl-, 2-hetaryl-, and 2-cyclopropyl-5-nitropyridines and 2,3-polymethylene-5-nitropyridines were synthesized by reactions of 1-methyl-3,5-dinitropyridin-2(1H)-one with various cyclic and acyclic ketones in the presence of ammonia.

  DOI：

  10.1134/s1070428009070112

文献信息

• [EN] NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS IMMUNOMODULATEURS ET ANTI-INFLAMMATOIRES
  申请人：INCOZEN THERAPEUTICS PVT LTD

  公开号：WO2011138665A1

  公开（公告）日：2011-11-10

  The present invention provides dihydroorotate dehydrogenase inhibitors of formula (I), methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.

  本发明提供了式(I)的脱氢二氢乳酸脱氢酶抑制剂，其制备方法，含有它们的药物组合物以及治疗、预防和/或改善已知抑制二氢乳酸脱氢酶显示有益效果的疾病或疾病的方法。
• Agent for Treatment of Eye Diseases
  申请人：Kakizuka Akira

  公开号：US20140148416A1

  公开（公告）日：2014-05-29

  The present invention provides agents effective to treat eye diseases, pharmaceutical compositions comprising them, methods for preparing pharmaceuticals for treatment of eye diseases comprising using the agents, use of the agents in manufacture of pharmaceuticals for treatment of eye diseases and methods for treating eye diseases comprising administering the agents or the pharmaceutical compositions. The eye diseases treated by the present invention include particularly glaucoma, especially normal tension glaucoma, or retinitis pigmentosa. The present invention provides the compound of formula (I) wherein R is as defined in the description.

  本发明提供了治疗眼部疾病的有效药剂，包括它们的制药组合物，制备用于治疗眼部疾病的药物的方法，包括使用这些药剂，以及在制造用于治疗眼部疾病的药物时使用这些药剂的方法，以及通过给药这些药剂或药物组合物来治疗眼部疾病的方法。本发明治疗的眼部疾病包括青光眼，特别是正常张力青光眼，或色素性视网膜病变。本发明提供了式（I）的化合物，其中R在说明中定义。
• Naphthalene Derivative
  申请人：Kakizuka Akira

  公开号：US20130184241A1

  公开（公告）日：2013-07-18

  The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I) (R is as defined in the description) or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.

  本发明提供了可以调节VCP活性的化合物。本发明提供了式(I)的化合物（其中R如描述中所定义）或其氧化物、酯、前药、药学上可接受的盐或溶剂。这些化合物可以调节VCP活性，因此可用于治疗VCP介导的疾病，如神经退行性疾病。
• Immunomodulator and anti-inflammatory compounds
  申请人：Muthuppalaniappan Meyyappan

  公开号：US08686048B2

  公开（公告）日：2014-04-01

  The present invention provides dihydroorotate dehydrogenase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.

  本发明提供了二氢乳酸脱氢酶抑制剂、其制备方法、含有它们的药物组合物以及治疗、预防和/或改善已知抑制二氢乳酸脱氢酶对某些疾病或疾病症状具有有益作用的方法。
• Cross-coupling study of iodo/chloropyridines and 2-chloroquinoline with atom-economic triarylbismuth reagents under Pd-catalysis
  作者：Maddali L.N. Rao、Ritesh J. Dhanorkar

  DOI：10.1016/j.tet.2014.11.036

  日期：2015.1

  This study describes the palladium-catalyzed couplings of iodopyridines, chloropyridines, and chloroquinoline with atom-economic BiAr3 reagents in sub-stoichiometric loadings. Mono-arylations of iodo and chloropyridines produced arylpyridines in high yields. The couplings addressed with dihalopyridines have afforded chemo- and regio-selective coupling products. Arylations of 2-chloroquinoline with different triarylbismuth reagents demonstrated fruitful coupling reactivity under the established conditions. This sumptuous study demonstrates the remarkable cross-coupling reactivity of iodo/chloropyridines and chloroquinoline with triarylbismuth reagents. (C) 2014 Elsevier Ltd. All rights reserved.